Ornithine Transcarbamylase Deficiency | Diagnosis & Treatments
Gene therapy for OTC deficiency
Boston Children’s recently participated in a gene therapy trial for patients with late-onset OTC. The therapy used an adenovirus vector to deliver a healthy copy of the OTC gene through an IV infusion. For more information, contact gene.therapy@childrens.harvard.edu.